| RIRGX | TIBCX | RIRGX / TIBCX | |
| Total Expense Ratio | 0.26 | 1.90 | 14% |
| Annual Report Gross Expense Ratio | 0.26 | 1.90 | 14% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 9.734 | 16.655 | 58% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 5000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 128B | 22.8B | 561% |
| Annual Yield % from dividends | 3.04 | 2.55 | 119% |
| Returns for 1 year | 10.64 | 27.32 | 39% |
| Returns for 3 years | 40.73 | 82.05 | 50% |
| Returns for 5 years | 41.61 | 94.93 | 44% |
| Returns for 10 years | 70.03 | 156.48 | 45% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BVEIX | 23.23 | 0.16 | +0.69% |
| Becker Equity Fund Institutional | |||
| LRSQX | 14.55 | 0.03 | +0.21% |
| Lord Abbett Small Cap Value R2 | |||
| CBFAX | 42.21 | -0.02 | -0.05% |
| American Funds Global Balanced 529-A | |||
| FBTDX | 172.63 | -0.63 | -0.36% |
| Franklin Biotechnology Discovery C | |||
| GAGPX | 13.21 | -0.35 | -2.58% |
| Goldman Sachs Em Mkts Eq Insghts P | |||